Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N-of-1 Trials in Cancer Drug Development. | Cancer Discov | 2023 | 37070849 | PubTator, text mining | PubMed |
| Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications. | Clin Cancer Res | 2023 | 37061987 | PubTator, text mining | PubMed |
| The kinesin light chain-2, a target of mRNA stabilizing protein HuR, inhibits p53 protein phosphorylation to promote radioresistance in NSCLC. | Thorac Cancer | 2023 | 37055376 | PubTator, text mining | PubMed |
| Gigaxonin is required for intermediate filament transport. | FASEB J | 2023 | 37043392 | PubTator, text mining | PubMed |
| Generation of recombinant and chickenized scFv versions of an anti-kinesin monoclonal antibody H2. | Cytoskeleton (Hoboken) | 2023 | 37036074 | PubTator, text mining | PubMed |
| Cellular cartography: Towards an atlas of the neuronal microtubule cytoskeleton. | Front Cell Dev Biol | 2023 | 37035244 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Editorial: Advances in Alzheimer's disease diagnostics, brain delivery systems, and therapeutics. | Front Mol Biosci | 2023 | 37006608 | PubTator, text mining | PubMed |
| Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology. | Front Cell Neurosci | 2023 | 37006471 | PubTator, text mining | PubMed |
| Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers. | BMC Cancer | 2023 | 37004022 | PubTator, text mining | PubMed |
| Response to selpercatinib in a patient with RET fusion-positive pulmonary large-cell neuroendocrine carcinoma: A case report. | Front Oncol | 2023 | 36998440 | PubTator, text mining | PubMed |
| Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis. | Diagn Pathol | 2023 | 36998041 | PubTator, text mining | PubMed |
| Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers. | Clin Cancer Res | 2023 | 36996322 | PubTator, text mining | PubMed |
| In Silico Exploration of Metabolically Active Peptides as Potential Therapeutic Agents against Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2023 | 36982902 | PubTator, text mining | PubMed |
| Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital. | Cancers (Basel) | 2023 | 36980591 | PubTator, text mining | PubMed |
| Exosomes: New regulators of reproductive development. | Mater Today Bio | 2023 | 36969697 | PubTator, text mining | PubMed |
| Small molecule-nanobody conjugate induced proximity controls intracellular processes and modulates endogenous unligandable targets. | Nat Commun | 2023 | 36964170 | PubTator, text mining | PubMed |
| [Biomarker MET in tumor pathology]. | Pathologie (Heidelb) | 2023 | 36944766 | PubTator, text mining | PubMed |
| Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions. | Acta Neuropathol | 2023 | 36933012 | PubTator, text mining | PubMed |
| A central chaperone-like role for 14-3-3 proteins in human cells. | Mol Cell | 2023 | 36931259 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=16